Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Medical Devices Registration in India in 2026: CDSCO Requirements and Approval Guide

Explore the CDSCO medical device registration pathway, including risk classification, Indian Authorized Agent requirements, Form MD-14 and Form MD-15, technical dossier preparation, common approval delays, and inspection-ready evidence under the Medical Devices Rules 2017.
  • Blog, Medical Devices
Medical device registration process in India showing CDSCO review, technical documentation, medical device classification in India, and regulatory approval requirements.

Hippocratic AI Buys Grove AI; Who Validates AI-Led Patient Screening?

Hippocratic AI acquired Grove AI in January 2026 after the startup spent two years building voice agents for clinical trial recruitment. Grove’s technology speaks with patients, collects screening information and helps match them with enrolling studies. The deal shows how
  • News
Hippocratic AI Buys Grove AI; Who Validates AI-Led Patient Screening?

Novo’s IL-6 Drug Lowered Inflammation; ZEUS Phase 3 Still Failed to Cut Heart Risk

Novo Nordisk reported that ziltivekimab failed to reduce major cardiovascular events in the Phase 3 ZEUS trial, despite lowering inflammation through IL-6 inhibition. The Denmark-based company tested the drug in more than 6,300 patients with cardiovascular disease, chronic kidney disease
  • News
Novo’s IL-6 Drug Lowered Inflammation; ZEUS Phase 3 Still Failed to Cut Heart Risk

Treasury Weighs China Biotech Curbs; Security Move Could Trigger a Hidden GMP Risk

US policymakers are debating whether the US Treasury should extend outbound investment controls to biotechnology transactions involving China. John Stanford, executive director at Incubate, warned that broad restrictions could affect licensing, investment and development partnerships as Chinese companies play a
  • News
Treasury Weighs China Biotech Curbs; Security Move Could Trigger a Hidden GMP Risk

$43 Billion China Biotech Rush; Can US Pharma Verify the CMC Evidence?

Chinese biotech licensing deals have become a major source of global drug pipelines. Pharmaceutical Executive reported more than $43 billion in licensing commitments during the first five months of 2026, while US lawmakers proposed broader scrutiny of biotechnology investments linked
  • News
$43 Billion China Biotech Rush; Can US Pharma Verify the CMC Evidence?

FDA Medical Devices Registration in 2026: 510(k), Device Listing, and Compliance Guide

Learn how FDA device registration and listing connects with classification, product codes, 510(k) pathways, FURLS records, annual renewal, and inspection readiness. The guide also explains common data gaps that can delay imports or threaten U.S. market access.
  • Blog, Medical Devices
Medical device compliance dashboard showing FDA medical device classification, product codes, FURLS device registration, 510(k) records, import checks, and establishment listing controls.

The Experiment Worked: Why Scientific Rationale Disappears Before CMC

A July 29, 2026 Pharmaceutical Technology feature by Christian Olsen examines a recurring failure in biologics R&D: systems preserve experimental results while losing the reasoning behind them. As candidates move from discovery into lead optimization, CMC and scale-up, missing context
  • News
The Experiment Worked: Why Scientific Rationale Disappears Before CMC

GSK Moves 1,000 Scientists: Cambridge Relocation Puts Validation Under Pressure

GSK announced a £400 million plan on July 28, 2026, to establish a 300,000-square-foot global R&D centre on the Cambridge Biomedical Campus. The company plans to move more than 1,000 UK scientists to Cambridge, leave its Stevenage R&D site through
  • News
GSK Moves 1,000 Scientists: Cambridge Relocation Puts Validation Under Pressure

FDA Proposes One Registration: Can Quality Systems Control Every Manufacturing Unit?

The FDA proposed a new registration pathway on July 10, 2026, for distributed manufacturing networks that operate through a hub-and-spoke model. If finalized, the FDA distributed manufacturing rule would let qualifying networks register as one establishment instead of registering every
  • News
FDA Proposes One Registration: Can Quality Systems Control Every Manufacturing Unit?

Medical Device Registration in 2026: Complete Guide to FDA, EU MDR, and Global Compliance

This guide explains how manufacturers manage device classification, FDA listing, EU MDR conformity assessment, CE marking, UDI, EUDAMED, technical documentation, and post-market controls to reduce registration delays, inspection findings, and global market-access risks throughout the product lifecycle.
  • Blog, Medical Devices
Medical devices, technical documentation, UDI labels, and compliance records illustrating FDA medical device registration, EU medical device registration, and global approval requirements.